alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

111TH CONGRESS 

1ST SESSION S. 274 

To amend the Internal Revenue Code of 1986 to provide an incentive to 

hire unemployed veterans. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 16, 2009 

Mr. BAUCUS introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To amend the Internal Revenue Code of 1986 to provide 

an incentive to hire unemployed veterans. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Veterans Jobs Oppor5 tunity Act of 2009’’. 

6 SEC. 2. INCENTIVE TO HIRE UNEMPLOYED VETERANS. 

7 (a) IN GENERAL.—Subsection (d) of section 51 of the 

8 Internal Revenue Code of 1986 is amended by adding at 

9 the end the following new paragraph: 


wwoods2 on PRODPC68 with BILLS
2 

•S 274 IS

1 ‘‘(14) CREDIT ALLOWED FOR UNEMPLOYED

2 VETERANS HIRED IN 2009 OR 2010.— 

3 ‘‘(A) IN GENERAL.—Any unemployed vet4 eran who begins work for the employer during 

5 2009 or 2010 shall be treated as a member of 

6 a target group for purposes of this subpart. 

7 ‘‘(B) UNEMPLOYED VETERAN.—For pur8 poses of this paragraph, the term ‘unemployed 

9 veteran’ means any veteran (as defined in para10 graph (3)(B), determined without regard to 

11 clause (ii) thereof) who is certified by the des12 ignated local agency as— 

13 ‘‘(i) having been discharged or re14 leased from active duty in the Armed 

15 Forces during 2008, 2009, or 2010, and 

16 ‘‘(ii) being in receipt of unemployment 

17 compensation under State or Federal law 

18 for not less than 4 weeks during the 1-year 

19 period ending on the hiring date.’’. 

20 (b) EFFECTIVE DATE.—The amendments made by 

21 this section shall apply to individuals who begin work for 

22 the employer after December 31, 2008. 

Æ 


wwoods2 on PRODPC68 with BILLS
<TABLE> <S> <C>

<ARTICLE>                                5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM WORLDTEX,
INC. FORM 10-K FOR THE PERIOD ENDED  DECEMBER 31, 1998 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                            1,000
       
<S>                                      <C>
<PERIOD-TYPE>                            YEAR
<FISCAL-YEAR-END>                        DEC-31-1998
<PERIOD-END>                             DEC-31-1998
<CASH>                                   6,715
<SECURITIES>                             0
<RECEIVABLES>                            42,885
<ALLOWANCES>                             2,041
<INVENTORY>                              58,515
<CURRENT-ASSETS>                         112,097
<PP&E>                                   153,918
<DEPRECIATION>                           40,266
<TOTAL-ASSETS>                           324,120
<CURRENT-LIABILITIES>                    38,945
<BONDS>                                  198,246
<PREFERRED-MANDATORY>                    0
<PREFERRED>                              0
<COMMON>                                 147
<OTHER-SE>                               73,335
<TOTAL-LIABILITY-AND-EQUITY>             324,120
<SALES>                                  258,537
<TOTAL-REVENUES>                         258,537
<CGS>                                    216,267
<TOTAL-COSTS>                            216,267
<OTHER-EXPENSES>                         0
<LOSS-PROVISION>                         590
<INTEREST-EXPENSE>                       18,765
<INCOME-PRETAX>                          (6,392)
<INCOME-TAX>                             (494)
<INCOME-CONTINUING>                      (5,898)
<DISCONTINUED>                           0
<EXTRAORDINARY>                          0
<CHANGES>                                0
<NET-INCOME>                             (5,898)
<EPS-PRIMARY>                              (.41)
<EPS-DILUTED>                            (.41)
        

</TABLE>
**Justification for Exception Position 3 (level AD-F) hired under the DOI AD Hiring Authority**

*Exception Position 3 requires skills acquired through specific job training or experience.  Work is performed independently.  The incumbent of the position is expected to interpret instructions, plan work, and lead or supervise positions at the next lower level.*

**NPS hiring unit:**

**Title of Exception Position:**

**Objective or purpose of position:**

**Duties:**

**Position will be supervised by (provide position title):**

**Qualifications/training of AD employee that justifies or supports hiring him/her into this position:**

_____________________________________________		____________________________

**Name of person providing this description (please print)	Date**

_____________________________________________		____________________________

**Signature approval of NPS National Incident Bus. Lead		Date**

# image1.png
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2552 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2552

      To extend the temporary suspension of duty on carbamic acid.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 30, 2009

  Mr. Burris introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
      To extend the temporary suspension of duty on carbamic acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CARBAMIC ACID.

    (a) In General.--Heading 9902.33.61 of the Harmonized Tariff 
Schedule of the United States (relating to ((3-
((Dimethylamino)carbonyl)-2-pyridinyl)sulfonyl) carbamic acid, phenyl 
ester) is amended by striking ``12/31/2009'' and inserting ``12/31/
2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
No. 980.

#### Riggs, Special Guardian, *v.*Del Drago et al.

March 30, 1942.

*Messrs. John W. Davis*and *Otis T. Bradley*for petitioner. *Messrs. Henry Cohen*and *Ludwig M. Wilson*for Giovanni Del Drago et al., and *Messrs. Joseph C. Thomson*and *Littleton Fox*for Byron Clark, Jr., Executor, respondents. *Messrs. John J. Bennett, Jr.,*Attorney General of New York, and *Henry Epstein,*Solicitor General, filed a brief on behalf of the State of New York, as *amicus curiae,*in support of the petition.

Petition for writ of certiorari to the Surrogate’s Court, New York County, New York, granted.
**EXHIBIT 31.1****CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**I, Mark L. Weinstein, President and Chief Executive Officer of Bio-Imaging Technologies, Inc.,certify that:1. I have reviewed this Quarterly Report on Form 10-Q of Bio-Imaging Technologies, Inc. 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  b) [Paragraph omitted in accordance with SEC transition instructions contained inSEC Release 34-47986]  c) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  d) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):
 

 
 a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.        Dated: May 15, 2007 /s/ Mark L. Weinstein   Mark L. Weinstein   President and Chief Executive Officer(Principal Executive Officer)
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2663 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2663

 To suspend temporarily the duty on DCDNBTF Benzene, 2,4-dichloro-1,3-
                      dinitro-5-(trifluoroethyl)-.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 2, 2009

   Mr. Burr introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To suspend temporarily the duty on DCDNBTF Benzene, 2,4-dichloro-1,3-
                      dinitro-5-(trifluoroethyl)-.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DCDNBTF BENZENE, 2,4-DICHLORO-1,3-DINITRO-5-
              (TRIFLUOROETHYL)-.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00       DCDNBTF Benzene,    Free         No change        No change        On or before 12/ ''.
                          2,4-dichloro-1,3-                                                  31/2011.......
                          dinitro-5-
                          (trifluoroethyl)-
                          (CAS No. 393-75-
                          9) (provided for
                          in subheading
                          2904.90.47)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<PAGE>
                                                                      Exhibit 32

                                CERTIFICATION (1)

      Pursuant to Section 906 of the Public Company Accounting Reform and
Investor Protection Act of 2002 (18 U.S.C. Section 1350, as adopted), Emile
Loria, M.D., the Chief Executive Officer of Epimmune Inc. (the "Company"), and
Robert De Vaere, the Chief Financial Officer of the Company, each hereby
certifies that, to the best of his knowledge:

1. The Company's Quarterly Report on Form 10-Q for the period ended June 30,
2003, to which this Certification is attached as Exhibit 99.1 (the "Periodic
Report"), fully complies with the requirements of Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Periodic Report fairly presents, in all
material respects, the financial condition of the Company at the end of the
period covered by the Periodic Report and results of operations of the Company
for the period covered by the Periodic Report.

Dated:   August 14, 2003

/s/ Emile Loria                                       /s/ Robert J. De Vaere
------------------------                              --------------------------
Emile Loria, M.D.                                     Robert J. De Vaere
Chief Executive Officer                               Chief Financial Officer


---------------------
(1) This certification accompanies the Form 10-Q to which it relates, is not
deemed filed with the SEC and is not to be incorporated by reference into any
filing of the Company under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended (whether made before or after the
date of the Form 10-Q, irrespective of any general incorporation language
contained in such filing).
# Aerial Supervision
#### CLARVIT v. J. G. WHITE ENGINEERING CORPORATION (PRELOAD CO., Third-Party Defendant).

District Court, S. D. New York.

Feb. 7, 1945.

Tippett, Cotter & Carey, of New York City (William P. Cotter, of New York City, of counsel), for third-party defendant, Preload Co.

Glenney, Mathews & Hampton, of New York City (Michael A. Hayes, of New York City, of counsel), for defendant and third-party plaintiff, J. G. White Engineering Corporation.

COXE, District Judge.

The third-party complaint in this case does not seek to hold Preload Company as a joint tort-feasor, but rather as an indemnitor on a remedy over; it is not, therefore, open to objection under Brown v. Cranston, 2 Cir., 132 F.2d 631, 148 A.L.R. 1178, certiorari denied. Cranston v. Thompson, 319 U.S. 741, 63 S.Ct. 1028, 87 L.Ed. 1698. See Tomko v. City Bank Farmers Trust Co., D.C., 3 F.R.D. 31. Whether the White Company is entitled to any benefit from the liability clauses of the contract between the Government and *144Preload Company is doubtful, but that question can best be determined at the trial after the facts have been shown. The allegations of the third-party complaint still remain, however, to the effect that the White Company was, at most, guilty only of passive or secondary negligence, and the Preload Company guilty of primary negligence. These allegations, if proved, are enough under the New York authorities. Oceanic Steam Navigation Co. v. Compania Transatlantica Espanola, 134 N.Y. 461, 31 N.E. 987, 30 Am.St.Rep. 685; Phoenix Bridge Co. v. Creem, 102 App.Div. 354, 92 N.Y.S. 855, affirmed 185 N.Y. 580, 78 N.E. 1110; Schwartz v. Merola Bros. Construction Corp., 290 N.Y. 145, 48 N.E.2d 299. The motion of the third-party defendant, Preload Company, to dismiss the third-party complaint is denied.
EXHIBIT 32.2



                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                           AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of YoCream International, Inc. (the
Company) on Form 10-Q for the quarter ended July 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, W.
Douglas Caudell, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-
Oxley Act of 2002, that:

    (1)   The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
    (2)   The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


Date:     September 15, 2003                By:   /s/ W. Douglas Caudell
                                            W. Douglas Caudell, Chief
                                            Financial Officer


This certification is made solely for the purpose of 18 U.S.C. Section 1350,
and not for any other purpose.  A signed original of this written statement
required by Section 906 has been provided to YoCream International, Inc. and
will be retained by YoCream International, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We have issued our reports
dated December 23, 2007, accompanying the consolidated financial statements included in the Annual Report of Hemagen Diagnostics, Inc. on Form 10-KSB for the year ended September 30, 2007. We hereby consent to the incorporation by
reference of said reports in the Registration Statements of Hemagen Diagnostics, Inc on Forms S-3 (File No. 33-40606 and No. 333-124425) and the Registration Statement on Form S-8 (File No. 333-57080)



|                   
|-------------------
|Stegman & Company  
|Baltimore, Maryland
|December 26, 2007
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service 

# AGENCY:

Internal Revenue Service (IRS), Treasury. 

# ACTION:

Notice. 

# SUMMARY:

This document provides notice of the availability of application packages for the 2010 Community Volunteer Income Tax Assistance (VITA) Matching Grant Program. 

# DATES:

                        Application packages are available from the IRS at this time. The deadline for submitting an application to the IRS is July 17, 2009. Electronic copies of the application package can be obtained by visiting:                         *http://www.irs.gov*                         (key word search—“VITA Grant”). Application packages may also be requested by sending an e-mail to                         *Grant.Program.Office@irs.gov.*                         Applications must be submitted by mail. The mailing address is listed below. Applications will not be accepted via                         *grants.gov*                         due to the expected increase in system activity resulting from the American Recovery and Reinvestment Act of 2009.                     

# ADDRESSES:

Application packages should be mailed to: Internal Revenue Service, Grant Program Office, 401 West Peachtree St., NW., Stop 420-D, Atlanta, GA 30308. 

# FOR FURTHER INFORMATION CONTACT:

                        Grant Program Office (404) 338-7894 (not a toll free number). The e-mail address is                         *Grant.Program.Office@irs.gov.*

# SUPPLEMENTARY INFORMATION:

Authority for the 2010 Community Volunteer Income Tax Assistance (VITA) Matching Grant Demonstration Program for tax return preparation is contained in H. R. 1105 Omnibus Appropriations Act, 2009 (Division D—Financial Services and General Government Appropriations Act, 2009). 

Dated: May 12, 2009. 

Elizabeth Blair, 

Chief, Grant Program Office. 

 [FR Doc. E9-12169 Filed 5-29-09; 8:45 am] 

BILLING CODE 4830-01-P
Exhibit 13.1

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002

(Subsection (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsection (a) and (b) of section 1350, chapter 63 of title 18,
United States Code), the undersigned officer of KT Corporation, a corporation organized under the laws of the Republic of Korea (the Company), does hereby certify, to such officers knowledge, that:

The annual report on Form 20-F for the year ended December 31, 2010 (the Form 20-F) fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operation of the Company.



/s/ SUK-CHAE LEESuk-Chae LeeChief Executive Officer


Date:
June 29, 2011



/s/ YEON-HAK KIMYeon-Hak KimExecutive Vice President andChief Financial Officer


Date:
June 29, 2011

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002
has been provided to KT Corporation and will be retained by KT Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 32

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In
connection with the Annual Report of Ventana Medical Systems, Inc., a Delaware corporation (the Company), on Form 10-K for the year ending December 31, 2006, as filed with the Securities and Exchange Commission (the
Report), Christopher Gleeson, President, Chief Executive Officer, and Director of the Company, and Nicholas Malden, Senior Vice President, Chief Financial Officer, and Secretary of the Company, respectively, do each hereby certify,
pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to their knowledge:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                    
|--------------------------------------------------------------------
|                                                                    
|/s/    CHRISTOPHER
GLEESON                                          
|Christopher Gleeson President, Chief Executive Officer, and Director

February 16, 2007



|                                                                             
|-----------------------------------------------------------------------------
|                                                                             
|/s/    NICHOLAS MALDEN                                                       
|Nicholas Malden Senior Vice President, Chief Financial Officer, and Secretary

February 16, 2007